See more : Laxai Pharma, Ltd. (LAXAF) Income Statement Analysis – Financial Results
Complete financial analysis of Bullfrog AI Holdings, Inc. Common Stock (BFRG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bullfrog AI Holdings, Inc. Common Stock, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Neueon Towers Limited (NTL.NS) Income Statement Analysis – Financial Results
- Data#3 Limited (DTL.AX) Income Statement Analysis – Financial Results
- Ibersol, S.G.P.S., S.A. (IBS.LS) Income Statement Analysis – Financial Results
- Landmark Bancorp, Inc. (LARK) Income Statement Analysis – Financial Results
- Nanjing Port Co., Ltd. (002040.SZ) Income Statement Analysis – Financial Results
Bullfrog AI Holdings, Inc. Common Stock (BFRG)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.bullfrogai.com
About Bullfrog AI Holdings, Inc. Common Stock
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 65.00K | 10.00K | 0.00 | 0.00 |
| Cost of Revenue | 5.20K | 800.00 | 0.00 | 0.00 |
| Gross Profit | 59.80K | 9.20K | 0.00 | 0.00 |
| Gross Profit Ratio | 92.00% | 92.00% | 0.00% | 0.00% |
| Research & Development | 1.43M | 609.27K | 0.00 | 0.00 |
| General & Administrative | 3.99M | 1.86M | 555.36K | 347.19K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.99M | 1.86M | 555.36K | 347.19K |
| Other Expenses | 0.00 | 459.00 | 0.00 | 0.00 |
| Operating Expenses | 5.43M | 2.47M | 555.36K | 347.19K |
| Cost & Expenses | 5.43M | 2.47M | 555.36K | 347.19K |
| Interest Income | 183.70K | 459.00 | 0.00 | 0.00 |
| Interest Expense | 79.09K | 347.15K | 40.40K | 11.77K |
| Depreciation & Amortization | 1.73K | 1.05K | 236.56K | 206.30K |
| EBITDA | -5.28M | -2.45M | -555.36K | -347.19K |
| EBITDA Ratio | -8,115.47% | -24,542.97% | 0.00% | 0.00% |
| Operating Income | -5.37M | -2.46M | -555.36K | -347.19K |
| Operating Income Ratio | -8,257.73% | -24,558.01% | 0.00% | 0.00% |
| Total Other Income/Expenses | 11.66K | -346.69K | -30.48K | 5.50K |
| Income Before Tax | -5.36M | -2.80M | -585.84K | -341.69K |
| Income Before Tax Ratio | -8,239.80% | -28,024.87% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 347.60K | -196.16K | -194.53K |
| Net Income | -5.36M | -2.80M | -585.84K | -341.69K |
| Net Income Ratio | -8,239.80% | -28,024.87% | 0.00% | 0.00% |
| EPS | -0.89 | -0.46 | -0.10 | -0.06 |
| EPS Diluted | -0.89 | -0.46 | -0.10 | -0.06 |
| Weighted Avg Shares Out | 6.05M | 6.09M | 5.65M | 5.65M |
| Weighted Avg Shares Out (Dil) | 6.05M | 6.09M | 5.65M | 5.65M |
BullFrog AI Announces Investor Webinar with CEO and Founder Vin Singh on Thursday, September 14, 2023
BullFrog AI Technology Licensed from Johns Hopkins University APL Named Finalist in R&D 100 Awards
Short squeeze alert for August 16th: Two stocks with high potential to soar
7 AI Stocks With High Short Interest
BullFrog AI: Soaring On Breaking News And AI Potential
BFRG Stock Alert: Why Is Bullfrog AI Up 30% Today?
BullFrog AI Announces Issuance of U.S. Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer
Generative AI to drive MedTech industry growth and innovation with failure to adopt key threat
BullFrog AI CEO Vin Singh to Present at the Gujarati Physicians Convention 2023
BullFrog AI CEO Vin Singh to Present at JMP Securities Life Sciences Conference
Source: https://incomestatements.info
Category: Stock Reports